Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Succinate Dehydrogenase (SDH)-Deficient Pancreatic Neuroendocrine Tumor Expands the SDH-Related Tumor Spectrum.

The Journal of clinical endocrinology and metabolism - 1 Oct 2015

Niemeijer Nicolasine D, Papathomas Thomas G, Korpershoek Esther, de Krijger Ronald R, Oudijk Lindsey, Morreau Hans, Bayley Jean-Pierre, Hes Frederik J, Jansen Jeroen C, Dinjens Winand N M, Corssmit Eleonora P M

Abstract excerpt

CONTEXT: Mutations in genes encoding the subunits of succinate dehydrogenase (SDH) can lead to pheochromocytoma/paraganglioma formation. However, SDH mutations have also been linked to nonparaganglionic tumors. OBJECTIVE: The objective was to investigate which nonparaganglionic tumors belong to the SDH-associated tumor spectrum. DESIGN: This was a retrospective cohort study. SETTING: The setting was a tertiary...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to DNA Mutational Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Loss of Heterozygosity

Share to Neuroendocrine Tumors

Share to Pancreatic Neoplasms

Share to Pedigree

Share to Pituitary Neoplasms

Share to Succinate Dehydrogenase

Source

Identifiers

PMID: 26259135
DOI: 10.1210/jc.2015-2689

Genes

SDHA
SDHB
SDHC
SDHD

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Succinate Dehydrogenase (SDH)-Deficient Pancreatic Neuroendocrine Tumor Expands the SDH-Related Tumor Spectrum.PMID 26259135Read ↗

Non-pheochromocytoma (PCC)/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC-PGL syndromes: a clinicopathological and molecular analysis.Semantic proximity Read ↗

Succinate dehydrogenase (SDH)‐deficient neoplasiaSemantic proximity Read ↗

Succinate Dehydrogenase-deficient TumorsSemantic proximity Read ↗

Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia.Semantic proximity Read ↗

Succinate dehydrogenase deficiency is rare in pituitary adenomas.Semantic proximity Read ↗

Germline SDHB and SDHD mutations in pheochromocytoma and paraganglioma patientsSemantic proximity Read ↗

Succinate Dehydrogenase (SDH) D Subunit (SDHD) Inactivation in a Growth-Hormone-Producing Pituitary Tumor: A New Association for SDH?Semantic proximity Read ↗

SDHA is a tumor suppressor gene causing paraganglioma.Semantic proximity Read ↗

The Role of the Surgical Pathologist in the Recognition of Hereditary SDH-Deficient Tumor Syndromes.Semantic proximity Read ↗

The Role of Immunohistochemistry and Molecular Analysis of Succinate Dehydrogenase in the Diagnosis of Endocrine and Non-Endocrine Tumors and Related SyndromesSemantic proximity Read ↗

Back to Biochemistry: Evaluation for and Prognostic Significance of SDH Mutations in Paragangliomas and Pheochromocytomas.Semantic proximity Read ↗

Back to Biochemistry: Evaluation for and Prognostic Significance of SDH Mutations in Paragangliomas and Pheochromocytomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.